
Release date: 2026-02-05 17:09:29 Article From: Lucius Laos Recommended: 166
Some medications are absolutely contraindicated for combined use. For other medications, even if drug interactions may occur, they can still be used under the guidance of a physician. In such cases, the doctor may adjust the dosage or take other necessary preventive measures.
During treatment with this medication, you must inform your healthcare providers of all the following drugs you are taking (the interactions listed are screened based on potential clinical significance and do not cover all possibilities):
Not recommended for combined use: The doctor may discontinue Cabozantinib or adjust other medications you are taking.
Bacillus Calmette-Guérin (BCG) vaccine (live attenuated vaccine).
Quadrivalent dengue live attenuated vaccine.
Measles live attenuated vaccine.
Mumps live attenuated vaccine.
Rubella live attenuated vaccine.
Smallpox/monkeypox vaccine.
Typhoid vaccine.
Varicella live attenuated vaccine.
Yellow fever vaccine.
Other medical conditions may affect the use of this medication. Be sure to inform your doctor of all your other health conditions, especially the following:
Hemorrhagic disorders, thrombotic diseases, acute myocardial infarction, heart disease, uncontrolled hypertension, hypocalcemia, hypothyroidism, proteinuria, gastric fistula/perforation, recent stroke: Use with caution; these conditions may be exacerbated.
Dental problems, dental procedures/surgery, poor oral hygiene, dental infections: May increase the risk of severe jaw disorders.
Recent hematemesis, hemoptysis, history of severe bleeding, melena: Contraindicated.
Mild to moderate liver disease: Use with caution; delayed drug clearance may enhance the drug’s efficacy.
Severe liver disease: Contraindicated.
Store in a sealed container at room temperature, away from heat sources, moisture, direct sunlight, and do not freeze.
Keep out of reach of children.
Do not retain expired or unused medications. Consult your healthcare provider for proper disposal methods.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended:[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended:[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended:[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended:[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended:[list:visits]2026-15-07
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulat···【more】
Recommended:[list:visits]2026-14-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643